Genmab A/S (GMAB)
34.74
+0.20
(+0.59%)
USD |
NASDAQ |
Sep 18, 16:00
34.74
0.00 (0.00%)
After-Hours: 20:00
Genmab Market Cap : 20.74B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 20.74B |
| September 17, 2026 | 20.62B |
| September 16, 2026 | 20.54B |
| September 15, 2026 | 20.39B |
| September 14, 2026 | 19.49B |
| September 11, 2026 | 19.39B |
| September 10, 2026 | 19.24B |
| September 09, 2026 | 19.73B |
| September 08, 2026 | 20.02B |
| September 04, 2026 | 20.06B |
| September 03, 2026 | 20.54B |
| September 02, 2026 | 20.43B |
| September 01, 2026 | 19.87B |
| August 31, 2026 | 19.80B |
| August 28, 2026 | 19.84B |
| August 27, 2026 | 20.36B |
| August 26, 2026 | 20.15B |
| August 25, 2026 | 20.51B |
| August 24, 2026 | 19.71B |
| August 21, 2026 | 19.97B |
| August 20, 2026 | 19.95B |
| August 19, 2026 | 20.36B |
| August 18, 2026 | 19.68B |
| August 17, 2026 | 19.61B |
| August 14, 2026 | 19.07B |
| Date | Value |
|---|---|
| August 13, 2026 | 18.71B |
| August 12, 2026 | 18.76B |
| August 11, 2026 | 18.42B |
| August 10, 2026 | 18.43B |
| August 07, 2026 | 18.66B |
| August 06, 2026 | 17.81B |
| August 05, 2026 | 17.47B |
| August 04, 2026 | 17.81B |
| August 03, 2026 | 17.60B |
| July 31, 2026 | 17.72B |
| July 30, 2026 | 17.58B |
| July 29, 2026 | 17.51B |
| July 28, 2026 | 17.80B |
| July 27, 2026 | 17.68B |
| July 24, 2026 | 17.72B |
| July 23, 2026 | 17.91B |
| July 22, 2026 | 17.71B |
| July 21, 2026 | 17.41B |
| July 20, 2026 | 17.13B |
| July 17, 2026 | 17.63B |
| July 16, 2026 | 17.79B |
| July 15, 2026 | 17.85B |
| July 14, 2026 | 17.64B |
| July 13, 2026 | 17.68B |
| July 10, 2026 | 17.80B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 466.44B |
| Ascendis Pharma A/S | 15.55B |
| Zealand Pharma A/S | 3.002B |
| Bavarian Nordic A/S | 2.417B |
| Evaxion AS | 27.27M |
Market Cap Related Metrics
| PE Ratio | 27.51 |
| PS Ratio | 5.364 |
| Price to Book Value | 3.482 |
| Price to Free Cash Flow | 25.47 |
| Price | 34.74 |
| Earnings Yield | 3.64% |
| Operating PE Ratio | 16.62 |
| Normalized PE Ratio | 22.55 |